The novel therapy of the medication represents a significant development in the care of diabetes mellitus type 2. Different to existing medications, tirzepatide impacts multiple pathways – GLP-1 and GIP – leading https://tirzepatide-peptide152637.blog-ezine.com/42672618/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment